Month: June 2026

23 Jun 2026

PExA signs agreement with global pharmaceutical company for 10 instruments for clinical multicenter study in pulmonary fibrosis, with a value of approximately SEK 7.5 million

News, Press Releases

PExA AB has signed an agreement with one of the world’s ten largest pharmaceutical companies regarding the delivery, installation and rental of ten PExA 2.1 systems for use in an international clinical study in idiopathic pulmonary fibrosis (IPF). Under the agreement, the customer will rent ten systems for a period of 18 months. The total…

10 Jun 2026

U.S. government agency customer orders upgrade of existing PExA system

News, Press Releases

PExA AB has received an order from a U.S. government agency customer, which is one of the world’s largest public funders of medical research, for the upgrade of an existing PExA 2.1 system. The upgrade adds new functionality intended to simplify and improve the efficiency of sample collection and sample handling in the customer’s research…

02 Jun 2026

New doctoral thesis strengthens PExA’s opportunities in lung cancer and other lung diseases

News, Press Releases

A new doctoral thesis from Lund University, entirely based on PExA’s technology for analysing exhaled particles from the lungs, strengthens the view of PExA as a platform for non-invasive biomarker analysis. The thesis shows how PExA-based breath samples can provide biologically relevant information across four different areas of lung disease: infection/COVID-19, lung transplantation, acute lung…

Month: June 2026

PExA signs agreement with global pharmaceutical company for 10 instruments for clinical multicenter study in pulmonary fibrosis, with a value of approximately SEK 7.5 million

U.S. government agency customer orders upgrade of existing PExA system

New doctoral thesis strengthens PExA’s opportunities in lung cancer and other lung diseases

Archive

Categories